Press release
Intra-Uterine Contraceptive Devices Market to Worth USD 4,851.2 Million with CAGR of 3.5% by 2024
The Global Intra-Uterine Contraceptive Devices Market is segmented on the basis of product type, end user, and geography.
Intra-Uterine Contraceptive Devices Market Categories: Segmentation
Global Intra-Uterine Contraceptive Devices Market, By Product Type (Hormonal IUCD, Copper IUCD), End-User (Hospitals, Gynaecology Clinics, Community Healthcare), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
For a Free Sample Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market
Global Intra-Uterine Contraceptive Devices Market: Market Drivers
Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.
Increased Rate of Unplanned Pregnancies:
Adolescents most commonly use contraceptive methods with relatively high typical use failure rates such as condoms, withdrawal, or oral contraceptive (OC) pills. Non-use, inconsistent use, and use of methods with high typical use failure rates are reflected in the high rate of unintended adolescent pregnancies in the U.S.
Rising Number of Initiatives Undertaken By the Private Firms:
The increasing number of initiatives taken by the U.S. government has helped to limit the rising number of unplanned pregnancies and abortions rate in the U.S. In addition, many U.S.-based private firms also contribute towards the solutions for pregnancy-related issues, which include maternal mortality, teenage pregnancies, growing number of abortions, and so on, by promoting the use of contraceptives, such as intrauterine contraceptive devices.
Favourable Insurance for IUCD’s:
The insurance policy is propelling the IUCD market towards growth. In Finland, national insurance covers acute but not preventive care, and contraceptives are usually paid by the patient. In Sweden, the copper IUCDs are available free of cost, whereas hormonal IUCDs are not. All FDA-approved contraceptives in the U.S. are covered by insurance.
Growing Awareness of Contraceptive:
The need to avoid unwanted pregnancies, especially among teenagers, is one of the major drivers for this market. It has also been observed that for over half of the users also identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain and acne, as reasons for use. This is also one of the factors contributing to the growth of the market in Europe.
Speak to Analyst Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-intra-uterine-contraceptive-devices-market
Some of the major players operating in this market are:
• Bayer AG
• Teva Pharmaceuticals Industries Ltd.
• Mona Lisa N.V.
• DKT International
• Egemen International
• Melbea AG, Ocon Medical Ltd.
• Pregna International Limited
• Medical Engineering Corporation SA
• SMB Corporation and Meril Life Sciences Pvt. Ltd.
• Medu Scientific Ltd
• China RH Contraceptives Co., Ltd
• Sanghai Jolly Medical Education Co., Ltd
• Bernstein Leibhard LLP
• ZheijangDaji Medical Instruments, Ltd.
• Nimble International
• AME Line
• Technico
• Cepeo
• Contraceptivos
• InjeflexInd
• Com Ltd
• Bersil
• Amed.
The Global Intra-Uterine Contraceptive Devices Market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Bayer AG dominated the IUCD devices market accounting for a highest market share in 2016, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed among others holds 34.0% of the IUCDdelivery market in 2016.
BAYER HEALTHCARE AG
Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science. The HealthCare segment offers a wide range of products under animal health, pharmaceuticals, consumer care, and medical care. The pharmaceutical business offers a wide range of products in the therapeutic area of oncology, haematology, and ophthalmology, and offers products for women’s health and cardiology therapeutic applications
Recent Developments:
In October 2016, Bayer AG has successfully concluded the European registration procedure to gain EUwide marketing authorization for its new low-dose levonorgestrel-releasing intrauterine system (LNGIUS). The product is named Kyleena and will be available in the market from 2017 January.
In September 2016, Bayer AG has successfully received FDA approval for its new low-dose levonorgestrel releasing intrauterine system (LNG-IUS) “Kyleena” The launch of this product in October in U.S.
Read more about the Global Intra-Uterine Contraceptive Devices Market visit @ http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/
Table of Content:
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
7. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
8. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE
9. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES
Related Report
Global Prosthetic Heart Valve Market – Trends and Forecast to 2024
Global Prosthetic Heart Valve Market, By Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)– Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-prosthetic-heart-valve-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intra-Uterine Contraceptive Devices Market to Worth USD 4,851.2 Million with CAGR of 3.5% by 2024 here
News-ID: 718673 • Views: …
More Releases from Data Bridge Market Research
Cancer Diagnostics Market to Reach USD 199.32 Billion by 2032, Expanding at a CA …
As per Data Bridge Market Research analysis, the Cancer Diagnostics Market was estimated at USD 118.59 billion in 2025. The market is expected to grow from USD 127.73 billion in 2026 to USD 199.32 billion in 2032, at a CAGR of 7.70% during the forecast period with driven by the rising demand for early cancer detection, advancements in diagnostic technologies, and increasing global cancer burden."
The market growth is primarily supported…
Molecular Biology Kits and Reagents Market to Reach USD 137.64 Billion by 2033, …
The Molecular Biology Kits and Reagents Market was estimated at USD 25.90 billion in 2025. The market is expected to grow from USD 31.91 billion in 2026 to USD 137.64 billion in 2033, at a CAGR of 23.22% during the forecast period with driven by the rising demand for advanced genomics research, increasing adoption of molecular diagnostics, and expanding applications in personalized medicine.
Get the full PDF sample copy of the…
Bioinformatics Market to Reach USD 57.03 Billion by 2032, Expanding at a CAGR of …
As per Data Bridge Market Research analysis, the Bioinformatics Market was estimated at USD 16.97 billion in 2025. The market is expected to grow from USD 20.18 billion in 2026 to USD 57.03 billion in 2032, at a CAGR of 18.90% during the forecast period with driven by the rising demand for genomic research."
The global bioinformatics market is witnessing robust expansion due to increasing adoption of genomic sequencing, integration of…
Saudi Arabia and GCC Modular Construction Market to Reach USD 4.93 billion by 20 …
As per Data Bridge Market Research analysis, the Microneedle Drug Delivery Systems Market was estimated at USD 7.96 billion in 2025. The market is expected to grow from USD 3.52 billion in 2024 to USD 4.93 billion by 2032, at a CAGR of 4.30% during the forecast period with driven by the rising demand for minimally invasive drug delivery, increasing prevalence of chronic diseases, and advancements in transdermal delivery technologies.
The…
More Releases for Contraceptive
Prominent Contraceptive Devices Market Trend for 2025: Innovative Products In Th …
What industry-specific factors are fueling the growth of the contraceptive devices market?
The rising prevalence of sexually transmitted diseases (STDs) is expected to fuel the growth of the contraceptive device market. STDs, influenced by increased sexual activity and insufficient protection, are on the rise, making contraceptive devices, especially condoms, essential for reducing transmission risks. The UK Health Security Agency reported a 4.7% increase in new STI diagnoses in England in 2023,…
Contraceptive Devices Market - Revolutionizing Family Planning: Cutting-Edge Con …
Newark, New Castle, USA: The "Contraceptive Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contraceptive Devices Market: https://www.growthplusreports.com/report/contraceptive-devices-market/7763
This latest report researches the industry structure, sales, revenue,…
Contraceptive Drugs Market: Doctors on the cusp of launching the first male cont …
Contraceptive Drugs Market by Product (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), Age Group (15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years), and End User (Homecare, Hospitals, and Clinics): Global Opportunity Analysis and Industry Forecast, 2020-2027.
Download Sample Report at:
https://www.alliedmarketresearch.com/request-sample/9850
The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during…
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,…
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
